Pressure is mounting on Moderna and Pfizer to share vaccine technology with the developing world after the two biggest proxy advisers lent support to shareholder resolutions.
Institutional Shareholder Services has recommended that investors vote in favour of proposals by Oxfam America that would compel Moderna and Pfizer to commission third-party reports about transferring their vaccine technology.
The drive to expand access to the well-performing mRNA vaccines comes as Moderna unveiled strong trial results for a new “bivalent” vaccine.
您已阅读17%（540字），剩余83%（2580字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。